The Incidence of Head and Neck Cancer in East Sudan

Authors

  • Mona Mahmoud Abasher Port Sudan Oncology Centre P.O.C, Sudan
  • Amal Abdelhakam Sidahmed Port Sudan Oncology Centre P.O.C, Sudan
  • Asjad Abdelmoniem Port Sudan Oncology Centre P.O.C, Sudan
  • Hyffa Osman Mohamed Ahmed Port Sudan Oncology Centre P.O.C, Sudan

DOI:

https://doi.org/10.54536/ajmsi.v2i2.1746

Keywords:

Head and Neck Cancer, East of Sudan, Incidence, Risk Factors, Diagnosis, Treatment, Prevention

Abstract

This review aims to provide an updated and detailed overview of the incidence of head and neck cancer in the eastern region of Sudan, focusing on studies conducted between 2018 and 2023. It aims to shed light on changes in incidence rates, emerging risk factors, advancements in diagnostic techniques, treatment modalities, and preventive strategies. Accurate knowledge of the latest trends and developments in head and neck cancer incidence is essential for effective public health planning and intervention. One significant aspect that the review highlights is the limited number of head and neck surgeons in East Sudan. It emphasizes the need for specialized training in staging malignancies using head and neck anatomy, as this information is vital for determining appropriate treatment approaches. With a shortage of trained professionals, it becomes even more critical to enhance the anatomic understanding and staging capabilities in order to improve patient outcomes and optimize treatment plans. The review underscores the urgency of addressing this gap in healthcare infrastructure. By increasing the number of head and neck surgeons in East Sudan and providing them with the necessary training, the region can improve its capacity to accurately stage head and neck cancers, leading to more effective treatment decisions and improved patient care. This review provides a comprehensive resource for understanding the current landscape of head and neck cancer incidence in the eastern region of Sudan. It addresses recent trends, emerging risk factors, and the need for improved anatomic understanding and staging capabilities. The findings can guide policymakers, healthcare providers, and researchers in implementing targeted strategies to reduce the burden of head and neck cancer in East Sudan and improve patient outcomes.

Downloads

Download data is not yet available.

References

Allen, P. J., Kuk, D., Fernandez-del Castillo, C., Basturk, O., Wolfgang, C. L., Cameron, J. L., Lillemoe, K. D., Ferrone, C. R., Morales-Oyarvide, V., & He, J. (2017). Multi-institutional validation study of the American Joint Commission on Cancer changes for T and N staging in patients with pancreatic adenocarcinoma. Annals of surgery, 265(1), 185.

Almarzooqi, S., Hashim, M. J., Awwad, A., Sharma, C., Saraswathiamma, D., Albawardi, A., & Awwad Sr, A. (2023). Lower Prevalence of Human Papillomavirus in Head and Neck Squamous Cell Carcinoma in Middle Eastern Population: Clinical Implications for Diagnosis and Prevention. Cureus, 15(2).

Alsahafi, E., Begg, K., Amelio, I., Raulf, N., Lucarelli, P., Sauter, T., & Tavassoli, M. (2019). Clinical update on head and neck cancer: molecular biology and ongoing challenges. Cell death & disease, 10(8), 540.

Bhattacharjee, A., Chakraborty, A., & Purkaystha, P. (2006). Prevalence of head and neck cancers in the north east—an institutional study. Indian Journal of Otolaryngology and head and neck surgery, 58, 15-19.

Blumberg, J., Monjane, L., Prasad, M., Carrilho, C., & Judson, B. L. (2015). Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique. Cancer epidemiology, 39(6), 1000-1005.

Chaturvedi, A. K., Anderson, W. F., Lortet-Tieulent, J., Curado, M. P., Ferlay, J., Franceschi, S., Rosenberg, P. S., Bray, F., & Gillison, M. L. (2013). Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. Journal of clinical oncology, 31(36), 4550.

Cherry, K., Schwarz, R. A., Yang, E., Badaoui, H., Williams, M. D., Vigneswaran, N., Gillenwater, A. M., & Richards-Kortum, R. (2018). Noninvasive autofluorescence imaging for tracking and monitoring the progression of oral premalignant lesions. Clinical and Translational Biophotonics.

Chiesa-Estomba, C. M., Lechien, J. R., Ayad, T., Calvo-Henriquez, C., González-García, J. Á., Sistiaga-Suarez, J. A., Dequanter, D., Fakhry, N., Melesse, G., & Piazza, C. (2021). Clinical and histopathological risk factors for distant metastasis in head and neck cancer patients. Acta Otorhinolaryngologica Italica, 41(1), 6.

da Cruz Perez, D. E., de Abreu Alves, F., Nishimoto, I. N., De Almeida, O. P., & Kowalski, L. P. (2006). Prognostic factors in head and neck adenoid cystic carcinoma. Oral oncology, 42(2), 139-146.

De Carvalho, A. C., Kowalski, L. P., Campos, A. H. J. F. M., Soares, F. A., Carvalho, A. L., & Vettore, A. L. (2012). Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients. Oral oncology, 48(3), 240-248.

Doobaree, I. U., Landis, S. H., Linklater, K. M., El-Hariry, I., Moller, H., & Tyczynski, J. (2009). Head and neck cancer in South East England between 1995–1999 and 2000–2004: an estimation of incidence and distribution by site, stage and histological type. Oral oncology, 45(9), 809-814.

Gavrielatou, N., Doumas, S., Economopoulou, P., Foukas, P. G., & Psyrri, A. (2020). Biomarkers for immunotherapy response in head and neck cancer. Cancer treatment reviews, 84, 101977.

Galbiatti, A. L. S., Padovani-Junior, J. A., Maníglia, J. V., Rodrigues, C. D. S., Pavarino, É. C., & Goloni-Bertollo, E. M. (2013). Head and neck cancer: causes, prevention and treatment. Brazilian journal of otorhinolaryngology, 79, 239-247.

Gebril, M. A. B., Mukhtar, W. N. O., Elhassan, M. M. A., & Mahmoud, I. (2022). Incidence Characteristics and Histological Types of Head and Neck Cancer among Adults in Central Sudan: A Retrospective Study. International Journal of Environmental Research and Public Health, 19(21), 13814.

Giannis, D., Cerullo, M., Moris, D., Shah, K. N., Herbert, G., Zani, S., Blazer 3rd, D. G., Allen, P. J., & Lidsky, M. E. (2021). Validation of the 8th edition American Joint Commission on Cancer (AJCC) gallbladder cancer staging system: Prognostic discrimination and identification of key predictive factors. Cancers, 13(3), 547.

Grégoire, V., Langendijk, J. A., & Nuyts, S. (2015). Advances in radiotherapy for head and neck cancer. Journal of clinical oncology, 33(29), 3277-3284.

Harris, A. T., Rennie, A., Waqar-Uddin, H., Wheatley, S. R., Ghosh, S. K., Martin-Hirsch, D. P., Fisher, S. E., High, A. S., Kirkham, J., & Upile, T. (2010). Raman spectroscopy in head and neck cancer. Head & neck oncology, 2(1), 1-6.

Hashim, D., Genden, E., Posner, M., Hashibe, M., & Boffetta, P. (2019). Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Annals of Oncology, 30(5), 744-756.

Ibrahim, O. R., Lugga, A. S., Ibrahim, N., Aladesua, O., Ibrahim, L. M., Suleiman, B. A., & Suleiman, B. M. (2021). Impact of climatic variables on childhood severe malaria in a tertiary health facility in northern Nigeria. Sudanese Journal of Paediatrics, 21(2), 173.

Johnson, D. E., Burtness, B., Leemans, C. R., Lui, V. W. Y., Bauman, J. E., & Grandis, J. R. (2020). Head and neck squamous cell carcinoma. Nature reviews Disease primers, 6(1), 92.

Joko‐Fru, W. Y., Jedy‐Agba, E., Korir, A., Ogunbiyi, O., Dzamalala, C. P., Chokunonga, E., Wabinga, H., Manraj, S., Finesse, A., & Somdyala, N. (2020). The evolving epidemic of breast cancer in sub‐Saharan Africa: Results from the African Cancer Registry Network. International Journal of Cancer, 147(8), 2131-2141.

Jou, A., & Hess, J. (2017). Epidemiology and molecular biology of head and neck cancer. Oncology research and treatment, 40(6), 328-332.

Kong, L., & Birkeland, A. C. (2021). Liquid biopsies in head and neck cancer: current state and future challenges. Cancers, 13(8), 1874.

Lalla, R. V., Brennan, M. T., Gordon, S. M., Sonis, S. T., Rosenthal, D. I., & Keefe, D. M. (2019). Oral mucositis due to high-dose chemotherapy and/or head and neck radiation therapy. JNCI Monographs, 2019(53), lgz011.

Liao, L.-J., Lo, W.-C., Hsu, W.-L., Wang, C.-T., & Lai, M.-S. (2012). Detection of cervical lymph node metastasis in head and neck cancer patients with clinically N0 neck—a meta-analysis comparing different imaging modalities. BMC cancer, 12, 1-7.

Mady, L. J., Kubik, M. W., Baddour, K., Snyderman, C. H., & Rowan, N. R. (2020). Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as “Personal Protective Equipment” for frontline providers exposed in high-risk head and neck and skull base oncology care. Oral oncology, 105, 104724.

Mody, M. D., Rocco, J. W., Yom, S. S., Haddad, R. I., & Saba, N. F. (2021). Head and neck cancer. The Lancet, 398(10318), 2289-2299.

Mosalleum, E. (2014). Epidemiology of oral malignancies in the Sudan.

Msyamboza, K. P., Dzamalala, C., Mdokwe, C., Kamiza, S., Lemerani, M., Dzowela, T., & Kathyola, D. (2012). Burden of cancer in Malawi; common types, incidence and trends: national population-based cancer registry. BMC research notes, 5, 1-8.

Pai, S. I., & Westra, W. H. (2009). Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annual Review of Pathology: Mechanisms of Disease, 4, 49-70.

Papillomaviruses, H. (2011). IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France: IARC.

Perri, F., Ionna, F., Longo, F., Scarpati, G. D. V., De Angelis, C., Ottaiano, A., Botti, G., & Caponigro, F. (2020). Immune response against head and neck cancer: biological mechanisms and implication on therapy. Translational Oncology, 13(2), 262-274.

Peter, F., Wittekindt, C., Finkensieper, M., Kiehntopf, M., & Guntinas-Lichius, O. (2013). Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients. Journal of cancer research and clinical oncology, 139, 171-178.

Ritchie, A. I., & Singanayagam, A. (2020). Immunosuppression or hyperinflammation in COVID-19: a double-edged sword. Lancet, 395(10230), 1111.

Russell, M. L. (2015). Nursing Implications of Radiation Therapy. Core Curriculum for Oncology Nursing-E-Book, 226.

Sabatini, M. E., & Chiocca, S. (2020). Human papillomavirus as a driver of head and neck cancers. British journal of cancer, 122(3), 306-314.

Saunders, G. R., Wang, X., Chen, F., Jang, S.-K., Liu, M., Wang, C., Gao, S., Jiang, Y., Khunsriraksakul, C., & Otto, J. M. (2022). Genetic diversity fuels gene discovery for tobacco and alcohol use. Nature, 612(7941), 720-724.

Scott, A. M., Gunawardana, D. H., Bartholomeusz, D., Ramshaw, J. E., & Lin, P. (2008). PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study. Journal of Nuclear Medicine, 49(10), 1593-1600.

Starzyńska, A., Sobocki, B. K., & Alterio, D. (2022). Current Challenges in Head and Neck Cancer Management. In Multidisciplinary Digital Publishing Institute, 14, 358.

Syrigos, K. N., Karachalios, D., Karapanagiotou, E. M., Nutting, C. M., Manolopoulos, L., & Harrington, K. J. (2009). Head and neck cancer in the elderly: an overview on the treatment modalities. Cancer treatment reviews, 35(3), 237-245.

Turbeville, H. R., Toni, T. A., & Allen, C. (2022). Immune Landscape and Role of Immunotherapy in Treatment of HPV-Associated Head and Neck Squamous Cell Carcinoma (HNSCC). Current Otorhinolaryngology Reports, 10(1), 96-107.

Van Leeuwen, M. T., Grulich, A. E., McDonald, S. P., McCredie, M. R., Amin, J., Stewart, J. H., Webster, A. C., Chapman, J. R., & Vajdic, C. M. (2009). Immunosuppression and other risk factors for lip cancer after kidney transplantation. Cancer epidemiology, biomarkers & prevention, 18(2), 561-569.

Wright, S. (2023). Flowchart. Care of Head and Neck Cancer Patients for Dental Hygienists and Dental Therapists, 53-53.

Zaryouh, H., Vara-Messler, M., Vignau, J., Machiels, J.-P., Wouters, A., Schmitz, S., & Corbet, C. (2022). Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine. Drug Resistance Updates, 100806.

Zhou, L., Mudianto, T., Ma, X., Riley, R., & Uppaluri, R. (2020). Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti–PD-1 Resistance in Head and Neck CancerEZH2 Is a Negative Regulator of HNSCC Antigen Presentation. Clinical Cancer Research, 26(1), 290-300.

Downloads

Published

2023-07-28

How to Cite

Abasher, M. M., Sidahmed, A. A., Abdelmoniem, A., & Mohamed Ahmed, H. O. (2023). The Incidence of Head and Neck Cancer in East Sudan. American Journal of Medical Science and Innovation, 2(2), 36–43. https://doi.org/10.54536/ajmsi.v2i2.1746

Most read articles by the same author(s)